Ercan I - Search Results

1

Comparison of the serum erythropoietin levels in chemotherapy-naive and cisplatin-treated cancer patients.

Arslan M, Evrensel T, Kurt E, Demiray M, Ercan I, Kanat O, Ozkan A, Manavoglu O. Arslan M, et al. Among authors: ercan i. Neoplasma. 2005;52(1):43-5. Neoplasma. 2005. PMID: 15739025

2

Evaluation of sex dimorphism of the mandible with geometric morphometric analysis: conventional and reconstructed panoramic radiography study.

Sessiz R, Ercan I, Özkan G, Toluk Ö. Sessiz R, et al. Among authors: ercan i. Surg Radiol Anat. 2023 Nov;45(11):1497-1504. doi: 10.1007/s00276-023-03201-z. Epub 2023 Jul 17. Surg Radiol Anat. 2023. PMID: 37460704

3

The role of triple therapy, age, gender and smoking on the genotoxic effects of Helicobacter pylori infection.

Gulten T, Tokyay N, Demiray M, Gulten M, Ercan I, Evke E, Sardas S, Karakaya AE. Gulten T, et al. Among authors: ercan i. J Int Med Res. 2002 Jul-Aug;30(4):380-5. doi: 10.1177/147323000203000403. J Int Med Res. 2002. PMID: 12235919 Free article. Clinical Trial.

4

Survival analysis of the factors affecting in mortality in injured patients requiring dialysis due to acute renal failure during the Marmara earthquake: survivors vs non-survivors.

Ersoy A, Yavuz M, Usta M, Ercan I, Aslanhan I, Güllülü M, Kurt E, Emir G, Dilek K, Yurtkuran M. Ersoy A, et al. Among authors: ercan i. Clin Nephrol. 2003 May;59(5):334-40. doi: 10.5414/cnp59334. Clin Nephrol. 2003. PMID: 12779094

5

Therapy, outcome and analysis of c-kit expression in patients with extrapulmonary small cell carcinoma.

Kurt E, Sezgin C, Evrensel T, Yalcinkaya U, Kanat O, Veral A, Demiray M, Arslan M, Karabulut B, Ercan I, Goker E, Manavoglu O. Kurt E, et al. Among authors: ercan i. Int J Clin Pract. 2005 May;59(5):537-43. doi: 10.1111/j.1368-5031.2005.00447.x. Int J Clin Pract. 2005. PMID: 15857349

6

Phase II study of gemcitabine plus paclitaxel in metastatic breast cancer patients with prior anthracycline exposure.

Demiray M, Kurt E, Evrensel T, Kanat O, Arslan M, Saraydaroglu O, Ercan I, Gonullu G, Gokgoz S, Topal U, Tolunay S, Tasdelen I, Manavoglu O. Demiray M, et al. Among authors: ercan i. Cancer Invest. 2005;23(5):386-91. doi: 10.1081/cnv-67133. Cancer Invest. 2005. PMID: 16193637 Clinical Trial.

7

Response to neoadjuvant chemotherapy in breast cancer could be predictable by measuring a novel serum apoptosis product, caspase-cleaved cytokeratin 18: a prospective pilot study.

Demiray M, Ulukaya EE, Arslan M, Gokgoz S, Saraydaroglu O, Ercan I, Evrensel T, Manavoglu O. Demiray M, et al. Among authors: ercan i. Cancer Invest. 2006 Nov;24(7):669-76. doi: 10.1080/07357900600981307. Cancer Invest. 2006. PMID: 17118776

8

Comparison of protracted infusion 5-fluorouracil and capecitabine in adjuvant chemoradiotherapy for rectal cancer.

Kurt M, Ozkan L, Kurt E, Cetintas SK, Aygun S, Ercan I, Yilmazlar T, Memik F. Kurt M, et al. Among authors: ercan i. Hepatogastroenterology. 2008 Jul-Aug;55(85):1158-63. Hepatogastroenterology. 2008. PMID: 18795649

9

Lack of genotoxicity in medical oncology nurses handling antineoplastic drugs: effect of work environment and protective equipment.

Gulten T, Evke E, Ercan I, Evrensel T, Kurt E, Manavoglu O. Gulten T, et al. Among authors: ercan i. Work. 2011;39(4):485-9. doi: 10.3233/WOR-2011-1198. Work. 2011. PMID: 21811037

10

Comparison of three different treatment modalities in the management of cancer cachexia.

Kanat O, Cubukcu E, Avci N, Budak F, Ercan I, Canhoroz M, Olmez F. Kanat O, et al. Among authors: ercan i. Tumori. 2013 Mar-Apr;99(2):229-33. doi: 10.1177/030089161309900218. Tumori. 2013. PMID: 23748819 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

173 results

Search Page

Filters